Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind placebo-controlled Phase 2 study of topical DPK-060 in atopic dermatitis
2007-007103-32Phase 2Completed
- Sponsor
- DermaGen AB
- Start
- Jan 2008
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in atopic dermatitis (AD) comparing Topical DPK-060 with Topical placebo (2 arms). Primary endpoint: Microbial density on skin lesions. Started Jan 2008; status: completed.
02
Drugs
DPK-060
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2007-007103-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007103-32.